about
Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling scienc...
Read More
31.26
0.10
(0.32%)
409.8K
XNAS Volume
XNAS 03 Sep, 2025 5:30 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Moderately Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
Galapagos NV ADR Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..